| Join | Site Map | Contact | Home
General Information Meeting Agenda Abstracts Exhibits Sponsors Registration Hotel & Travel

 

 

 

On-line
Registration Kit

Agenda Overview

Environmental Impacts on the Genome and Epigenome: Mechanisms and Risks

EMS President: Jeffrey L. Schwartz
Program Chair: Catherine B. Klein

(information subject to change)

Friday | Saturday | Sunday | Monday | Tuesday | Wednesday

Tuesday, October 18
7:00 AM–5:00 PM
  Registration Inscription
7:00 AM–5:00 PM
  Speaker Ready Room Open Inscription 2
7:00 AM–8:30 AM
  Breakfast Meetings  
  Breakfast Pick-Up for Meetings (Ticket Required—Breakfast Available at 6:45 AM) Net Café
 

Executive Board Meeting
 

Longueuil
 

Epigenetics
Special Interest Group

Leaders: Janet E. Baulch, University of Maryland, Baltimore and Dana C. Dolinoy, University of Michigan

Fontaine F
 

New Technologies
Special Interest Group

Leaders: Brinda Mahadevan, Abbott Laboratories and Jennifer C. Sasaki, Alkermes, Inc.

Fontaine G
8:30 AM–9:30 AM
  EMS Award Lecture (PL3)
Human Exposure
Unraveling the Mystery of a Global Environmental Disease

Chairperson: Catherine B. Klein, New York University School of Medicine

Lecturer: Arthur P. Grollman, Stony Brook University

Outremont
8:30 AM–12:00 NOON
  Posters and Exhibits Open
Last Chance to View Posters and Exhibits!
Fontaine B
9:45 AM–12:15 PM
  Symposium 9
Whole Genome Mutational Profiling of Environmentally Induced Cancer

Chairpersons: James C. Fuscoe, National Center For Toxicological Research, U.S. FDA and David A. Wheeler, Baylor College of Medicine

Supported in part by: Quaility and Regulatory, Global Occupational Toxicology

Mont-Royal
9:45 AM–10:10 AM Updates on Next-Generation Sequencing and Bioinformatics
David A. Wheeler, Baylor College of Medicine
 
10:10 AM–10:35 AM Targeted Resequencing Using the PacBio RS Platform
John D. McPherson, Ontario Institute for Cancer Research
 
10:35 AM–11:00 AM Paired-End Sequencing Reveals Characteristic Patterns of Structural Variations in Epithelial Cancer Genomes
Guillaume Bourque, McGill University
 
11:00 AM–11:15 AM Break—In the Exhibit Hall  
11:15 AM–11:40 AM Landscape of Somatic Alterations in Cancer and Their Relationship to the Environment
Kristian Cibulskis, The Eli and Edythe L. Broad Institute
 
11:40 AM–12:05 PM  The Human SNP Site-Frequency-Spectrum
Richard A. Gibbs, Baylor College of Medicine
 
12:05 PM–12:15 PM 

Discussion

 
9:45 AM–12:15 PM
  Symposium 10
Transcription and Genetic Instability

Chairpersons: Malcolm J. Lippert, Saint Michael’s College and Mats Ljungman, The University of Michigan

Organized by the DNA Repair and Mutagenic Mechanisms Special Interest Group

Outremont
9:45 AM–10:10 AM Role for Topoisomerase I in Transcription-Associated Mutagenesis
Malcolm J. Lippert, Saint Michael’s College
 
10:10 AM–10:35 AM Transcription Impacts Genomic Stability via Multiple Mechanisms
Nayun Kim, Duke University Medical Center
 
10:35 AM–11:00 AM Transcription Associated Recombination at Replication Forks in Mammalian Cells
Thomas Helleday, Gray Institute for Radiation Oncology and Biology
 
11:00 AM–11:15 AM Break—In the Exhibit Hall  
11:15 AM–11:45 AM Transcription-Blockage by Lesions and Unusual DNA Structures
Philip C. Hanawalt, Stanford University
 
11:45 AM–12:15 PM 

The Transcriptome and the DNA Repairome
Mats Ljungman, University of Michigan

 
9:45 AM–12:15 PM
  Symposium 11
Low Dose Mutagenesis and Carcinogenesis

Chairpersons: Errol Zeiger, Errol Zeiger Consulting and David M. DeMarini, U.S. Environmental Protection Agency

Supported in Part by: ILSI-HESI IVGT Project Committee

Verdun
9:45 AM–9:50 AM Low-Dose Mutagenesis and Carcinogenesis: Why Is This Issue Important
Errol Zeiger, Errol Zeiger Consulting
 
9:50 AM–10:15 AM Low-Dose Mutagenicity Case Studies: MMS and MNU
Lynn H. Pottenger, The Dow Chemical Company
 
10:15 AM–10:40 AM Low-Dose In Vivo Study of Acrylamide
Errol Zeiger, Errol Zeiger Consulting
 
10:40 AM–11:00 AM   Low-Dose Carcinogenicity Studies
David M. DeMarini, U.S. Environmental Protection Agency
 
11:00 AM–11:15 AM Break—In the Exhibit Hall  
11:15 PM–11:40 PM  Analysis of Low-Dose Mutagenicity Responses and the Applicability of Genotoxicity Tests for Carcinogen Potency Prediction
Lya Hernandez, National Institute for Public Health and the Environment
 
11:40 PM–12:05 PM  Dose Response Issues in the Regulation of Chemicals
Rita Schoeny, U.S. Environmental Protection Agency
 
12:05 PM–12:15 PM  

Discussion

 
12:15 PM–2:00 PM
  Lunch on your own  
12:30 PM–1:45 PM
 

Lunch Meeting
(Advance Registration Required)

Women in the EMS Special Interest Group

Leaders: Janice M. Pluth, Lawrence Berkeley National Laboratory and Glenda J. Gentile, University of Arizona

Lecturer: Geraldine L. Richmond, COACh Program, University of Oregon

Fontaine F
2:00 PM–3:15 PM
  Symposium 12
Risks Associated with Inadvertent Exposures to Pharmaceutical and Prescription Drugs

Chairpersons: Brinda Mahadevan, Abbott Laboratories and Ainsley Weston, Centers for Disease Control and Prevention

Organized by the New Technologies Special Interest Group and the Applied Genetic Toxicology Special Interest Group

Mont-Royal
2:00 PM–2:15PM   Inadvertent Exposures to Pharmaceutical Drugs: Overview
Ainsley Weston, National Institute for Occupational Safety and Health, CDC
 
2:15 PM–2:35 PM  Risk-Based Manufacture of Pharmaceutical Products
Brinda Mahadevan, Abbott Laboratories
 
2:35 PM–2:55 PM Considerations for Risk Assessments of Genotoxic or Carcinogenic Impurities in Industry
John Nicolette, Abbott Laboratories
 
2:55 PM–3:15 PM 

Preventing Occupational Exposures to Antineoplastic Drugs in Health Care Settings
Thomas H. Connor, National Institute for Occupational Safety and Health, CDC

 
2:00 PM–3:15 PM
  Symposium 13
Using DNA Adducts in Risk Assessment: Approaches, Considerations, and Significance

Chairpersons: Lynn H. Pottenger, The Dow Chemical Company and Annie Jarabek, National Center for Environmental Assessment, U.S. EPA

Primary Sponsor: ILSI-HESI DNA Adducts Project Committee

Outremont
2:00 PM–2:25 PM ILSI-HESI DNA Adducts Project Committee: Review of Case Study Outcomes: Tamoxifen, AFB1, and VCI
Lynn H. Pottenger, The Dow Chemical Company
 
2:25 PM–2:40 PM Application of Decision Analytic Approach to Case Studies 
Annie Jarabek, National Center for Environmental Assessment, U.S. EPA
 
2:40 PM–3:00 PM    Mutagenesis and Repair of O6- and N7-Alkylguanine Adducts
Robert Fuchs, Centre National de la Recherche Scientifique
 
3:00 PM–3:15 PM

Relevance of DNA Adduct Approaches to Regulatory Risk Assessment
Rita Schoeny, U.S. Environmental Protection Agency

 
2:00 PM–4:45 PM
 

Platform Session 2
Mutagenesis and Carcinogenesis Mechanisms

Chairpersons: Ofelia A. Olivero, National Cancer Institute, NIH and Sandy K. Weiner, Johnson & Johnson

Presenting author is underlined.

Verdun
2:00 PM–2:15 PM Subchronic Oral Exposure to Benzo[a]Pyrene Induces Changes in Gene Expression Associated with Cellular Transformation in Mouse Lungs: A Toxicogenomics Study
Labib S¹, Williams A², Lemieux CL², White PA², Halappanavar S². ¹University of Ottawa, Ottawa, ON, Canada, ²Health Canada, Ottawa, ON, Canada
 
2:15 PM–2:30 PM The Mouse Diversity Genotyping Array Profiles Tissue- and Genotype-Specific Mutations across the Mouse Genome
Eitutis ST, Wishart AE, Hill KA. The University of Western Ontario, London, ON, Canada
 
2:30 PM–2:45 PM DNA Structure-Induced Genetic Instability in Mammals
Wang G, Vasquez K. University of Texas at Austin, Austin, TX, United States
 
2:45 PM–3:00 PM Identification of Different Mechanisms of Non-Genotoxic Carcinogens Based on Gene Expression Profiling in Primary Mouse Hepatocytes
Schaap MM1,2, Jonker MJ³, Zwart PE¹, Wackers P³, van de Water B4, Breit TM³, Schoonen WG5, Polman J5, van Steeg H1,2, Luijten M¹. ¹National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands, ²Department of Toxicogenetics, Leiden University Medical Center, Leiden, Netherlands, ³MicroArray Department and Integrative Bioinformatics Unit, University of Amsterdam, Amsterdam, Netherlands, 4Leiden Amsterdam Center for Drug Research (LACDR), Leiden University, Leiden, The Netherlands, 5Merck Sharp & Dome, Oss, Netherlands
 
3:00 PM–3:15 PM Tissue Specificity of Aristolochic Acid-Induced Carcinogenesis Examined by ACB-PCR Quantification of H-Ras Codon 61 CTA Mutant Fraction
Wang Y¹, McKim KL¹, Myers MB¹, Arlt VM², Parsons BL¹. ¹National Center for Toxicological Research, U.S. FDA, Jefferson, AR, United States, ²Institute of Cancer Research, Sutton, Surrey, United Kingdom
 
3:15 PM–3:30 PM Break  
3:30 PM–3:45 PM Toxicogenomic Late Effects of Antineoplastic Therapies for Lymphomas
Marcondes JPC¹, Torres BP¹, Niéro-Melo L¹, Gaiolla RD¹, Luisi FAV², Salvadori DMF¹. ¹São Paulo State University, Botucatu, SP, Brazil, ²São Paulo Federal University, São Paulo, SP, Brazil
 
3:45 PM–4:00 PM

Functional Studies of Single-Nucleotide Polymorphic Variants of Human Glutathione Transferase T1-1 Involving Residues in the Dimer Interface
Josephy PD¹, Pan D¹, Ianni MD¹, Mannervik B2,3. ¹University of Guelph, Guelph, Canada, ²Uppsala University, Uppsala, Sweden, ³Stockholm University, Stockholm, Sweden

 
4:00 PM–4:15 PM Analyzing the Relationship between Radiation-Induced Phospho-Protein Signaling and Surrogate Cancer Endpoints Using Novel Flow-Based Assays
Whalen MK¹, Sridharan DM¹, Wilson W¹, Chapell L², Cucinotta FA², Pluth JM¹. ¹Lawrence Berkeley National Laboratory, Berkeley, CA, United States, ²Lyndon B. Johnson Space Center, Houston, TX, United States
 
4:15 PM–4:30 PM Lethal Mutagenesis of HIV and Cancer Cells by Nucleoside Analogs
Fox EJ¹, Shen JC¹, Prindle MJ¹, Harris KS4, Mullins JI³, Essigmann JM5, Loeb LA1,2. ¹Department of Pathology, University of Washington, Seattle, WA, United States, ²Department of Biochemistry, University of Washington, Seattle, WA, United States, ³Department of Microbiology, University of Washington, Seattle, WA, United States, 4Koronis Pharmaceuticals, Seattle, WA, United States, 5Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, United State
 
4:30 PM–4:45 PM Role of the Circadian Clock in UV-Induced Skin Carcinogenesis
Gaddameedhi S, Selby CP, Sancar A. University of North Carolina, Chapel Hill, NC, United States
 
3:15 PM–3:30 PM
  Break  
3:30 PM–4:45 PM
  Symposium 14
Environmental Oil Contamination: Effects on Marine Life and Human Life

Chairpersons: Christopher M. Somers, University of Regina and Miriam C. Poirier, National Cancer Institute, NIH

Organized by the Molecular Epidemiology Special Interest Group and the Environmental Genetic Toxicology Special Interest Group

Mont-Royal
3:30 PM–3:45 PM Voyage 2 of the Odyssey: The Impact of the Oil Crisis on Health Using Whales As an Indicator Species
John Wise, University of Southern Maine
 
3:45 PM–4:00 PM  NIOSH Health Hazard Evaluation Conducted in the Aftermath of the Deepwater Horizon (DWH) Disaster
Ainsley Weston, National Institute for Occupational Safety and Health, CDC
 
4:00 PM–4:15 PM  Are Seafood Safety Considerations Adequate to Prevent Chronic Health Effects of the Deep Water Horizon Oil Spill on Coastal Louisiana Residents?
Patricia L. Williams, University of New Orleans
 
4:15 PM–4:30 PM  Overview of the Toxicity of the Oil Dispersant Corexit
David M. DeMarini, U.S. Environmental Protection Agency
 
4:30 PM–4:45 PM 

Panel Discussion

 
3:30 PM–4:45 PM
  Symposium 15
Intestinal Microbiota: A Key Player in Obesity, Genomic Instability, and Lymphoma

Chairperson: Robert H. Schiestl, UCLA School of Medicine and Public Health

Outremont
3:30 PM–4:00 PM  Intestinal Microbiota Affect Genetic Instability, Longevity and Lymphoma Latency in Atm-/- Mice
Robert H. Schiestl, UCLA School of Medicine and Public Health
 
4:00 PM–4:15 PM  The Intestinal Host-Microbial Ecosystem: A Systems Biology Approach to Inflammation and Cancer Risk
Jonathan Braun, David Geffen School of Medicine at UCLA
 
4:15 PM–4:30 PM Intestinal Microbiota Involved in Rheumatoid Arthritis
Jose U. Scher, New York University Langone Medical Center
 
4:30 PM–4:45 PM 

Discussion

 
5:30 PM–6:50 PM
  Public Lecture (L1)
Cancer in Beluga Whales from the St. Lawrence Estuary, Québec, Canada: A Case of “One Health, One Medicine”

Lecturer: Daniel Martineau, University of Montréal

Outremont